Showing results (161-170 of 207) with videos related to
Sort By:
Pageof 21
The Journal of Biological Chemistry|June 28, 2002
Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxelSeiji Mabuchi, Masahide Ohmichi, Akiko Kimura, et al.Endocrinology|August 27, 2005
Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cellsMaki Saitoh, Masahide Ohmichi, Kazuhiro Takahashi, et al.Endocrinology|June 11, 2005
Growth factors change nuclear distribution of estrogen receptor-alpha via mitogen-activated protein kinase or phosphatidylinositol 3-kinase cascade in a human breast cancer cell lineToshifumi Takahashi, Masahide Ohmichi, Jun Kawagoe, et al.Maturitas|October 3, 2006
Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapyKenjiro Sawada, Ken-Ichirou Morishige, Masahide Ohmichi, et al.International Journal of Molecular Sciences|September 10, 2021
Patient-Derived Xenograft Models in Cervical Cancer: A Systematic ReviewTomohito Tanaka, Ruri Nishie, Shoko Ueda, et al.Endocrinology|September 18, 2007
Involvement of RelA-associated inhibitor in regulation of trophoblast differentiation via interaction with transcriptional factor specificity protein-1Ryoko Minekawa, Masahiro Sakata, Yoko Okamoto, et al.Abdominal Radiology (New York)|April 9, 2017
Pathological findings of uterine tumors preoperatively diagnosed as red degeneration of leiomyoma by MRIGo Nakai, Takashi Yamada, Takamitsu Hamada, et al.Journal of Clinical Medicine|May 14, 2022
Endometrial Cancer Patient-Derived Xenograft Models: A Systematic ReviewTomohito Tanaka, Ruri Nishie, Shoko Ueda, et al.Oncology Reports|September 10, 2015
CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancerTomohito Tanaka, Yoshito Terai, Yuhei Kogata, et al.Menopause (New York, N.Y.)|September 29, 2006
Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor alphaNamiko Yada-Hashimoto, Yukihiro Nishio, Masahide Ohmichi, et al.Pageof 21